Select Date
- >
Loading available days...
Available Slots:
Overview
Dr. Prasad Eswaran is a highly experienced Medical Oncologist based in Chennai, Tamil Nadu, with over 22 years of dedicated practice in the field. He is well-regarded for his comprehensive approach to cancer care, focusing on both medical management and patient support. Dr. Eswaran holds an impressive academic background, having earned his MBBS, DMRT, MD, and DM qualifications. His commitment to continuing education and the latest developments in oncology ensures that his patients receive the most effective and innovative treatment options available.
Fluent in English, Tamil, and Hindi, Dr. Eswaran effectively communicates with a diverse patient population, making him approachable and empathetic in his practice. He understands that a cancer diagnosis can be daunting, and he prioritizes patient education and involvement in care decisions, helping patients understand their treatment options and potential outcomes.
Dr. Eswaran is affiliated with Apollo Hospitals, a leading healthcare institution known for its advanced medical services. He is passionate about improving patient outcomes and has a strong interest in clinical research within oncology, contributing to advancements in cancer treatment. As a trusted physician, he has earned recognition for his patient-centered care and has built strong relationships with the individuals he serves. Dr. Prasad Eswaran is not just a medical professional but a compassionate advocate for his patients, working tirelessly to support them through their cancer journey.
Experience
03/2023 – Present Senior Consultant Medical Oncologist & Lead Apollo Proton Cancer Hospital, Chennai.
07/2017 – 03/2023 Head of the Department & Senior Medical Oncologist MIOT Institute of Cancer Cure, MIOT International, Chennai.
06/2016 – 06/2017 Consultant Medical Oncologist (Associate) Tata Medical Center, Kolkata, West Bengal, India.
09/2014 – 06/2016 Consultant Medical Oncologist, CBCC Cancer Center, Comprehensive Blood & Cancer Center (CBCC – India), Chennai.
11/2010 – 07/2011 Radiation Oncologist, Dept. of Radiation Oncology, Institute of Oncology, Apollo Specialty Hospital, Madurai, Tamil Nadu, India.
04/2008 – 10/2010 Clinical Oncologist, Dept. of Oncology, Indira Gandhi Govt. General Hospital & Post Graduate Institute, Puducherry, India.
06/2004 – 11/2005 Medical Officer in Emergency Room, Rotary Hospital, Chennai, Tamil Nadu, India.
03/2004 – 05/2004 Fellow in Emergency Room, Apollo Hospital, Chennai, Tamil Nadu, India.
Memberships
ECMO/AWARDED AMERICAN BRACHYTHERAPY SOCIETY RESIDENT HDR FELLOWSHIP FOR THE YEAR 2009.
Awards
- REVERSAL OF ACUTE STROKE IN YOUNGEST PATIENT IN THE COUNTRY BY MECHANICAL MEANS WAS DONE IN 2013
- Claimed the best paper award at the annual research meeting of medical research centre Bombay Hospital Trust for the paper on ‘Clinical outcome of Cervical Spondylotic Myelopathy with special reference to Myelomalacia’, Aug 2005
- Trained successfully neuro interventionalists of Shanghai China in mechanical thrombectomy .organized and invited by Changhai hospital Shanghai , China in April 2016
- SUCCESSFULLY TREATED FIRST REPORTED CASE OF BILATERAL DIRECT CAROTID CAVERNOUS FISTULA IN INDIA
Research and Publication
RESEARCH EXPERIENCE :
10/2013 - 12/2014 Shortlisted for fellowship / research grant for conducting research in major molecular pathways in brain tumors under the initiative on the Neurosciences Clinical Research Foundation (INCRE – 2013), Department of Biotechnology, Govt. of India.
12/2012 - 12/2014 Clinical study co-investigator of “An open label, multicenter, parallel group, comparative, randomized study to compare the safety and efficacy of Trastuzumab powder for solution for infusion with Herceptin® in patients with HER2 overexpressing metastatic breast cancer” at Dept. of Medical Oncology, Madras Medical College & Government General Hospital, Chennai, Tamil nadu, India.
NATIONAL (INDIA) ACADEMIC HONOURS ORAL PRESENTATIONS
03/2014 Oral presentation in Torrent Young Scholar Award 2014 - Competition among all D.M. (Medical Oncology) super specialty post graduates across all Indian Institutes conducted in Ahmedabad, Gujarat, India - Debate Topic - “EGFR Tyrosine Kinase Inhibitors in NSCLC - Against the motion”.
04/2014 Bronze medal winner in National level talent competition - Torrent Young Scholar Award 2014 - Competition among all D.M. (Medical Oncology) super specialty post graduates across all Indian Institutes conducted in Ahmedabad, Gujarat, India. 07/2012 Oral presentation in 8th American Head and Neck Society (AHNS) held at Toronto, Canada – “Concurrent chemoradiation with weekly Cisplatin, Docetaxel and Gefitinib – A study to assess feasibility, toxicity and immediate response”.
03/2012 Oral Presentation – Best Clinical Trial Proposal Award – presented in 26th Conference of Indian Cooperative Oncology Network (ICON), Bangalore, India – “Toxicity and Efficacy analysis of Triplet combination (Docetaxel / Oxaliplatin / Capecitabine) in advanced Gastric and Gastroesophageal Malignancy”.
09/2009 Oral Presentation – Best Thesis Presentation - Submission of results of Indian Cooperative Oncology Network (ICON) trial in National meet – Awarded first prize, Rupees 50,000 in 21st Conference of ICON, Tata Memorial Hospital, Mumbai, India – “Results of Phase I trial of weekly Paclitaxel and Cisplatin with Radiation Therapy in Carcinoma Cervix”. http://oncologyindia.org/Content.aspx?Show=5AlFDZkt7143notl9qLA
09/2006 Oral Presentation – Best Project Proposal award in National conference – Awarded Rupees 500,000 for conducting a trial – 15th Conference of Indian Cooperative Oncology Network (ICON), Trivandrum, Kerala, India – “Phase I trial of Weekly Paclitaxel as Radiosensitizer with Cisplatin and Radiation Therapy in the treatment of Carcinoma Cervix”. http://oncologyindia.org/Content.aspx?Show=5AlFDZkt7143notl9qLA
09/2005 Oral Presentation – Best paper presentation – Awarded Dr. Padam Singh Award – Association of Radiation Oncologist of India (AROI) – State Conference, September 2005, Madurai, Tamil Nadu, India – “Comparison of efficacy of 3 modalities in treatment of Carcinoma Cervix – Conventional, Hyperfractionation and Chemoradiation therapy”.
04/2000 Awarded Kishore Vyaganik Protshahik Yojna (KVPY) Scholarship, April 2000, Indian Councilof Medical Research (ICMR), New Delhi, India – “Assessment of socioeconomic aspects of 100 families in Royapuram, Chennai – A sample study in Chennai population
PUBLICATION
1. Arun P, Senthil KR, Prasad E. Diagnostic performance of Ga-68 FAPI 04 PET/CT in colorectal malignancies. Nuclear Medicine Communications. 4(4):p 276-283, April 2023. DOI: 10.1097/MNM.0000000000001661
2. Biswas B, Dabkara D, Ganguly S, Prasad E. Consolidation chemotherapy after concurrent chemoradiotherapy in locally advanced non-squamous non-small cell lung cancer: When, whom and how much? Natl Med J India. 2016 (in press).
3. Bivas Biswas, Deepak Dabkara, Sandip Ganguly, Prasad E, and Joydeep Ghosh. “Cytoreductive nephrectomy in metastatic renal cell carcinoma in the era of targeted therapy: scientifically relevant or natural selection?”. Accepted in Journal of Clinical Oncology. Article in Press.
4. Prasad Eswaran, Kannan K. “Phase I / II trial of combination chemotherapy with Docetaxel / Oxaliplatin / Capecitabine in advanced gastric cancers”. Clinical Cancer Investigation Journal 2015; 4: 504-10.
5. Prasad Eswaran, Velappan A, Kannan K. “Carcinoma stomach with Breast metastasis - unusual site of soft tissue deposit – A case report”. Status – Accepted for Publication - Med-ej: The official journal of The Tamilnadu Dr. M.G.R. Medical University.
6. Kannan K, Eswaran P, Ismail SR. “Management of High Risk Gestational Trophhoblastic Disease with brain metastases - A Single Institution Experience from 1996 to 2010”. Oncology, Gastroenterology and Hepatology Reports, Jan-Jun 2015, Vol 4, Iss 1, Page 1 - 3.
7. Eswaran P, Devadoss P, Narasimhan LS, Kannan K. “Monophasic Synovial Sarcoma of the Heart – A case report and Review of Literature” – Journal of Cancer Research and Therapeutics 2015; 11: 659. (Jul – Sep 2015). PMID:26458665.
8. Eswaran P, Azmi KS. “Concurrent chemoradiation with weekly Cisplatin, Docettaxel and Gefitinib: A study to assess feasibility, toxiciity and immediate response”. Journal of Cancer Research and Therapeutics 2013; 9: 392-6 (Jul – Seep 2013). PMID: 24125972.
9. Prasad E, Viswanathan P N, Faith Rangad V, Thomas Ram, Pavamani S et al. “Maximum Tolerated Dose: Results of Phase I trial of weekly Paclitaxel and Cisplatin with Radiation Therapy in Carcinoma Cervix” –Clinical Oncology, Vol 21, Iss 6, Pg 488-493 (August 2009). PMID: 19386478.
PUBLICATION (as abstracts) 1. Dabkara D, Ganguly S, Ghosh J, E Prasad, Biswas B. Metronomic cyclophosphamide in metastatic castrate resistant prostate cancer: Experience from a tertiary cancer care center. Annals of oncology 2016; 27 (Supplement 9):ix 90 [ 287 P].
2. Ganguly S, Biswas B, Dabkara D, E Prasad, Ghosh J, Bhaumik J, Midha D. Clinical profile of germ cell tumor of ovary - A single centre experience. Annals of oncology 2016; 27 (Supplement 9):ix 96 [ 305 PD].
Special Interests
HEAD AND NECKCANCER., BREAST CANCER,THORACIC MALIGNANCY, GI MALIGNANCY,GENITO -URINARY MALIGNANCY. BONE AND SOFT TISSUE CANCER, HEMATO-ONCOLOGY
Frequently Asked Questions
Where does Dr. Prasad E practice?
Dr. Prasad E is a practicing physician at Apollo Hospitals, Greams Road. This hospital offers comprehensive healthcare services.
Why do patients choose Dr. Prasad E?
Patients consult Dr. Prasad E for expertise in Medical Oncology, Chemotherapy, and Cancer Screening. His comprehensive approach to cancer care makes him a sought-after oncologist.
What do patients say about Dr. Prasad E?
Dr. Prasad E has received positive feedback from 3 patients and one patient story is available. Detailed patient testimonials can be accessed through our patient review platform.
What are Dr. Prasad E's medical qualifications?
Dr. Prasad E holds an MBBS, a Diploma in Medical Radiology, a DM in Oncology, and an MD in Radiotherapy.
What is Dr. Prasad E's medical specialty?
Dr. Prasad E specializes in Medical Oncology.
How many years of experience does Dr. Prasad E have?
Dr. Prasad E possesses 20 years of experience in oncology. His extensive medical career spans two decades.
Who is Dr. Prasad E?
Dr. Prasad E is a highly experienced medical oncologist specializing in head and neck, breast, and gynecological cancers. His career includes training and work at leading national and international institutions. He's earned numerous international fellowships and national honors for his contributions to successful clinical trials. Dr. Prasad is dedicated to providing comprehensive oncology care and improving the quality of life for cancer patients.
Who is an oncologist?
An oncologist is a medical doctor specializing in the diagnosis, treatment, and care of cancer patients across all tissues and organs. They are cancer specialists providing comprehensive oncology care.
What are the different branches of oncology?
Oncology comprises several specialties: medical oncology (chemotherapy), surgical oncology (tumor removal surgery), radiation oncology (radiation therapy), gynecologic oncology (female cancers), pediatric oncology (childhood cancers), and hematology-oncology (blood cancers).
What is the difference between a clinical and a medical oncologist?
Medical oncologists treat cancer using systemic therapies like chemotherapy, hormone therapy, and biological agents. Clinical oncologists utilize a combination of chemotherapy and radiotherapy.
